197 related articles for article (PubMed ID: 28329383)
1. Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.
Chico RM; Chaponda EB; Ariti C; Chandramohan D
Clin Infect Dis; 2017 Apr; 64(8):1043-1051. PubMed ID: 28329383
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
3. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
Yaya S; Kota K; Buh A; Bishwajit G
BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
[TBL] [Abstract][Full Text] [Related]
4. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
Diakite OS; Kayentao K; Traoré BT; Djimde A; Traoré B; Diallo M; Ongoiba A; Doumtabé D; Doumbo S; Traoré MS; Dara A; Guindo O; Karim DM; Coulibaly S; Bougoudogo F; Ter Kuile FO; Danis M; Doumbo OK
Clin Infect Dis; 2011 Aug; 53(3):215-23. PubMed ID: 21765069
[TBL] [Abstract][Full Text] [Related]
5. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P
PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859
[TBL] [Abstract][Full Text] [Related]
7. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
[TBL] [Abstract][Full Text] [Related]
8. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
9. Fetal growth and birth weight are independently reduced by malaria infection and curable sexually transmitted and reproductive tract infections in Kenya, Tanzania, and Malawi: A pregnancy cohort study.
Mtove G; Chico RM; Madanitsa M; Barsosio HC; Msemo OA; Saidi Q; Gore-Langton GR; Minja DTR; Mukerebe C; Gesase S; Mwapasa V; Phiri KS; Hansson H; Dodd J; Magnussen P; Kavishe RA; Mosha F; Kariuki S; Lusingu JPA; Gutman JR; Alifrangis M; Ter Kuile FO; Schmiegelow C
Int J Infect Dis; 2023 Oct; 135():28-40. PubMed ID: 37516425
[TBL] [Abstract][Full Text] [Related]
10. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
[TBL] [Abstract][Full Text] [Related]
11. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
[TBL] [Abstract][Full Text] [Related]
12. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
Chico RM; Chandramohan D
Trop Med Int Health; 2011 Jul; 16(7):774-85. PubMed ID: 21477099
[TBL] [Abstract][Full Text] [Related]
13. Uptake of four or more doses of sulfadoxine pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Zambia: findings from the 2018 malaria in pregnancy survey.
Sinyange D; Mukumbuta N; Mutale LS; Mumbole H; Hamainza B; Sialubanje C
BMJ Open; 2023 May; 13(5):e073287. PubMed ID: 37236665
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
[TBL] [Abstract][Full Text] [Related]
15. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis.
Kayentao K; Garner P; van Eijk AM; Naidoo I; Roper C; Mulokozi A; MacArthur JR; Luntamo M; Ashorn P; Doumbo OK; ter Kuile FO
JAMA; 2013 Feb; 309(6):594-604. PubMed ID: 23403684
[TBL] [Abstract][Full Text] [Related]
16. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
[TBL] [Abstract][Full Text] [Related]
17. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
Owusu-Boateng I; Anto F
Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
[TBL] [Abstract][Full Text] [Related]
18. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V
J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
[TBL] [Abstract][Full Text] [Related]
20. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
